Two Onc Docs

Епизоде

• 
  Metastatic Non-Small Cell Lung Cancer 2026 UPDATE 14.09.2026 13мин

  This week's episode focuses on metastatic non-small cell lung cancer - the quickly growing and changing systemic therapy landscape, including traditional chemotherapy, immunotherapy, and targeted agents. Since our last recording the number of FDA-approved targeted drugs has significantly expanded.
• 
  Non-Small Cell Lung Cancer 2026 UPDATE 31.08.2026 13мин

  This week's episode focuses on early-stage and locally advanced non-small cell lung cancer - staging, pathology, local and systemic therapy. Before we start, the usual caveat: the treatment landscape of NSCLC is changing FAST, which is exciting, but know that the boards run a few years behind. The big shifts since our last episode are the move to 9th-edition TNM staging and the arrival of four different perioperative chemo+immunotherapy regimens. Shout out to Dr. Bharathi Muthusamy for review...
• 
  Myelodysplastic Syndrome (MDS) 2026 UPDATE 24.08.2026 10мин

  Today’s episode is focusing on what you need to know regarding myelodysplastic syndrome (MDS). This will include the high yield facts on risk factors, diagnostic work-up, staging and treatment of MDS, we were overdue do this this topic, last done in 2022.
• 
  Iron Overload 2026 UPDATE 17.08.2026 22мин

  This week’s episode will be focusing on syndromes of iron overload. We will go over all important details on hemochromatosis and other related diseases. We last covered this topic in 2023.
• 
  How to Approach a New Malignancy 101 03.08.2026 14мин

  This week’s episode will be focusing on how to approach a newly diagnosed malignancy, biopsy, staging, patient considerations ect.
• 
  Tips for Heme/Onc Fellowship 2026 28.07.2026 17мин

  This week’s episode will be focusing on how to transition well into heme/onc fellowship including differences from residency, tips for surviving, wellness, resources & more.
• 
  DLBCL 2026 UPDATE 20.07.2026 12мин

  This week’s episode will be focusing on Diffuse Large B-Cell Lymphoma (DLBCL). We will go all the important details on this aggressive NHL which can be highly curable. We have some new changes since we last covered this topic in 2022 including a new category 1 option for advanced DLBCL
• 
  Wellness in Oncology with Dr. Laura Vater 13.07.2026 23мин

  This week’s episode we are back with our very special guest, friend and colleague Dr Laura Vater joining us to talk about wellness in oncology, and burnout prevention tips.
• 
  Transitioning from Fellow to Attending with Dr. Laura Vater 29.06.2026 19мин

  This week’s episode we have a very special guest, friend and colleague Dr. Laura Vater joining us to talk about one of the biggest transitions in medicine—moving from fellow to attending. Dr Vater is a GI oncologist at IU, writer, and speaker. She focuses on the dignity of patients and clinicians, and strives to keep healthcare human.
• 
  ASCO 2026 Plenary: SARC-041 22.06.2026 11мин

  This week’s episode will be focusing on an ASCO 2026 Plenary abstract, SARC 041. SARC041 is the first positive phase 3 randomized controlled trial of a CDK4/6 inhibitor in advanced dedifferentiated liposarcoma (DDLPS), demonstrating that abemaciclib significantly improves progression-free survival compared to placebo.
• 
  ASCO Annual Meeting 2026 GU Recap 15.06.2026 14мин

  Today we are recapping exciting GU data presented at the 2026 ASCO Annual Meeting in bladder cancer, kidney cancer, and prostate cancer.
• 
  ASCO 2026 Plenary: RASolute-302 08.06.2026 11мин

  This week’s episode will be focusing on the 2026 ASCO Plenary that received a standing ovation, the RASolute 302 trial. The RASolute 302 trial is a landmark phase 3 study demonstrating that daraxonrasib doubled overall survival compared to chemotherapy in previously treated (2L) metastatic pancreatic ductal adenocarcinoma (mPDAC).
• 
  ASCO Annual Meeting 2026 Preview 25.05.2026 11мин

  Today we will be focusing on exciting data to come at the ASCO Annual Meeting in 2026 in Chicago, with a special focus on GU sessions, educational sessions & med ed sessions.
• 
  Von Willebrand Disease (VWD) 2026 UPDATE 18.05.2026 13мин

  This week’s episode will be focusing on Von Willebrand disease (VWD), a highly testable bleeding disorder. We will go over all the important details on the diagnosis, types of VWD as well as treatment.
• 
  Aplastic Anemia 2026 UPDATE 11.05.2026 11мин

  Today’s episode is focusing on the highest yield facts about Aplastic Anemia. This will include the mechanism of AA, diagnostic work-up, treatment of AA, and the evolution of clones including PNH.
• 
  Metastatic Bladder Cancer 2026 UPDATE 04.05.2026 9мин

  Today’s episode is focusing on what you need to know regarding metastatic bladder cancer, with 2026 updates. This will include the need to know treatment options and toxicities for metastatic urothelial carcinoma, and also discuss the management of upper tract + variant non-urothelial histology.
• 
  Localized Bladder Cancer 2026 UPDATE 27.04.2026 13мин

  Today’s episode is focusing on what you need to know regarding localized bladder cancer, with 2026 updates. This will include the need to know pathology, presentation, diagnostic work-up, staging, and treatment options.
• 
  4 Years with Two Onc Docs 20.04.2026 12мин

  This week’s episode will be focusing on how we met, the future of the podcast, and why we picked heme/onc. This is a very different style of episode and a special once because this month is our 4 year anniversary of Two Onc Docs! And we will back to our regular programming next week with overdue updates on Bladder Cancer.
• 
  Pancreatic Cancer x Dr. Michael Pishvaian 2026 UPDATE Part 3 13.04.2026 14мин

  We are back with a very special guest Dr. Michael Pishvaian, who is an Associate Professor in GI Oncology at the Johns Hopkins Kimmel Cancer Center, and creator of Tumor Board Tuesday. In part 3, we discuss supportive care in pancreatic cancer, and exciting trials in this space.
• 
  Metastatic Pancreatic Cancer x Dr. Michael Pishvaian 2026 UPDATE Part 2 06.04.2026 25мин

  We are back with a very special guest Dr. Michael Pishvaian, who is an Associate Professor in GI Oncology at the Johns Hopkins Kimmel Cancer Center, and creator of Tumor Board Tuesday. In part 2, we will focus on metastatic pancreatic cancer, 1L treatments, maintenance therapy, targeted therapy + more.